Eupraxia Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $37,923,793.
Profit Margin
| 2017 | 0 | -4.31M | |
|---|---|---|---|
| 2020 | 0 | -3.99M | |
| 2023 | 0 | -37.39M |
EPRX Income Statement (2017 – 2023)
| 2023 | 2020 | 2017 | |
|---|---|---|---|
Revenue | |||
Revenue | 0 | 0 | 0 |
Cost of revenue | 209.91K | 116.80K | 85.37K |
Gross profit | -209.91K | -116.80K | -85.37K |
Operating exp. | |||
Research and development | 27.54M | 859.78K | 3.18M |
Selling and marketing | 0 | 0 | 0 |
Total operating expenses | 37.92M | 2.24M | 4.97M |
Operating income | -36.89M | -2.24M | -4.97M |
Other income (expenses), net | -2.28M | -1.76M | -143.13K |
Income before tax | -39.18M | -4.01M | -4.99M |
Income tax expense | -89.66K | 1.86M | -627.56K |
Net income | -37.39M | -3.99M | -4.31M |
Earnings per share | |||
Basic EPS | -1.58 | -0.31 | -0.34 |
Diluted EPS | -1.58 | -0.31 | -0.34 |
| Data source | Data source | Data source |